Sunday, 8 September 2024
  
Login

Australia's most trusted
source of pharma news

Sunday, 08 September 2024
Listen to this story 
News

CSL Vifor satisfies EC concerns

Posted 25 July 2024 AM

CSL Vifor has resolved its antitrust dispute with the European Commission, with a ten-year communication campaign.

Earlier this year the Australian giant offered commitments to the EC, which spent a month market testing those commitments and consulting interested third parties. Taking the outcomes of the market testing into consideration, CSL Vifor adjusted the commitments, and the EC has now accepted them and made them legally binding.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (22)

Clinical & Medical, R&D (13)

Regulatory, Pharmacovigilance & QA (6)

Other (10)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.